Healthcare provider profile · identity verified

David Labotka, MD

Internal Medicine · DOWNERS GROVE, IL · NPI 1205803178

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	713	204
Amlodipine Besylate	Amlodipine Besylate	566	146
Levothyroxine Sodium	Levothyroxine Sodium	528	135
Metformin Hcl	Metformin Hcl	410	114
Lisinopril	Lisinopril	341	95
Losartan Potassium	Losartan Potassium	319	83
Metoprolol Succinate	Metoprolol Succinate	318	92
Simvastatin	Simvastatin	311	95
Tamsulosin Hcl	Tamsulosin Hcl	272	77
Omeprazole	Omeprazole	232	62
Rosuvastatin Calcium	Rosuvastatin Calcium	224	77
Alprazolam	Alprazolam	209	59
Pantoprazole Sodium	Pantoprazole Sodium	204	66
Furosemide	Furosemide	171	52
Potassium Chloride	Potassium Chloride	154	42
Hydrochlorothiazide	Hydrochlorothiazide	144	41
Alendronate Sodium	Alendronate Sodium	142	38
Gabapentin	Gabapentin	138	33
Glimepiride	Glimepiride	137	41
Allopurinol	Allopurinol	135	37
Escitalopram Oxalate	Escitalopram Oxalate	131	38
Metoprolol Tartrate	Metoprolol Tartrate	129	32
Warfarin Sodium	Warfarin Sodium	127	17
Sertraline Hcl	Sertraline Hcl	120	31
Eliquis	Apixaban	118	25
Famotidine	Famotidine	118	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	108	32
Jardiance	Empagliflozin	108	27
Pravastatin Sodium	Pravastatin Sodium	101	24
Meloxicam	Meloxicam	99	44
Lorazepam	Lorazepam	95	23
Ezetimibe	Ezetimibe	92	23
Trazodone Hcl	Trazodone Hcl	91	20
Carvedilol	Carvedilol	89	22
Finasteride	Finasteride	89	20
Tramadol Hcl	Tramadol Hcl	85	24
Zolpidem Tartrate	Zolpidem Tartrate	81	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	79	45
Pioglitazone Hcl	Pioglitazone Hcl	77	23
Donepezil Hcl	Donepezil Hcl	76	21
Diclofenac Sodium	Diclofenac Sodium	75	30
Montelukast Sodium	Montelukast Sodium	75	11
Duloxetine Hcl	Duloxetine Hcl	70	26
Clopidogrel	Clopidogrel Bisulfate	69	18
Prednisone	Prednisone	69	44
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	68	suppressed
Baclofen	Baclofen	63	15
Fluticasone Propionate	Fluticasone Propionate	62	24
Acetaminophen-Codeine	Acetaminophen With Codeine	61	15
Clonazepam	Clonazepam	61	15
Doxycycline Hyclate	Doxycycline Hyclate	60	53
Hydralazine Hcl	Hydralazine Hcl	57	13
Memantine Hcl	Memantine Hcl	57	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	55	suppressed
Azithromycin	Azithromycin	52	44
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	13
Bupropion Xl	Bupropion Hcl	48	16
Esomeprazole Magnesium	Esomeprazole Magnesium	48	suppressed
Metformin Hcl Er	Metformin Hcl	47	17
Spironolactone	Spironolactone	47	14
Doxazosin Mesylate	Doxazosin Mesylate	46	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	34
Albuterol Sulfate Hfa	Albuterol Sulfate	44	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	42	suppressed
Buspirone Hcl	Buspirone Hcl	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	14
Fenofibrate	Fenofibrate Nanocrystallized	40	14
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Xarelto	Rivaroxaban	39	suppressed
Irbesartan	Irbesartan	38	11
Levofloxacin	Levofloxacin	38	31
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	38	27
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	11
Nifedipine Er	Nifedipine	36	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Torsemide	Torsemide	33	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	22
Atenolol	Atenolol	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	18
Ramipril	Ramipril	31	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Primidone	Primidone	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Gemtesa	Vibegron	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	18
Glipizide Er	Glipizide	26	suppressed
Lactulose	Lactulose	26	suppressed
Methenamine Hippurate	Methenamine Hippurate	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Diazepam	Diazepam	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Latanoprost	Latanoprost	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	16
Ozempic	Semaglutide	24	suppressed
Soaanz	Torsemide	24	suppressed
Topiramate	Topiramate	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	16
Dilt-Xr	Diltiazem Hcl	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Amoxicillin	Amoxicillin	22	14
Azelastine Hcl	Azelastine Hcl	22	suppressed
Glipizide	Glipizide	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Nystatin	Nystatin	22	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Propranolol Hcl	Propranolol Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Vancomycin Hcl	Vancomycin Hcl	20	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Digoxin	Digoxin	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Valsartan	Valsartan	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	16	suppressed
Hydrocortisone	Hydrocortisone	16	13
Lovastatin	Lovastatin	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Repatha Sureclick	Evolocumab	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	14	14
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Clonidine	Clonidine	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Repatha Syringe	Evolocumab	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Wegovy	Semaglutide	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error